NO20044768L - Sammensetning og terapeutisk anvendelse derav - Google Patents

Sammensetning og terapeutisk anvendelse derav

Info

Publication number: NO20044768L
Authority: NO; Norway
Prior art keywords: composition; therapeutic use; therapeutic; insulin; vitamin
Prior art date: 2002-05-29

Application number

NO20044768A

Other languages

English (en)

Norwegian (no)

Inventor

Mishal Hamid Al-Sari

Original Assignee

Veritron Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-29

Filing date

2004-11-03

Publication date

2005-02-24

2004-11-03 Application filed by Veritron Ltd filed Critical Veritron Ltd

2005-02-24 Publication of NO20044768L publication Critical patent/NO20044768L/no

Links

230000001225 therapeutic effect Effects 0.000 title abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
102000018997 Growth Hormone Human genes 0.000 abstract 1
108010051696 Growth Hormone Proteins 0.000 abstract 1
208000026350 Inborn Genetic disease Diseases 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
208000000453 Skin Neoplasms Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
208000016361 genetic disease Diseases 0.000 abstract 1
239000000122 growth hormone Substances 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
229910021645 metal ion Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
201000000849 skin cancer Diseases 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1
239000011782 vitamin Substances 0.000 abstract 1
229940088594 vitamin Drugs 0.000 abstract 1
229930003231 vitamin Natural products 0.000 abstract 1
235000013343 vitamin Nutrition 0.000 abstract 1
150000003722 vitamin derivatives Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Immunology (AREA)
Virology (AREA)
Oncology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Natural Medicines & Medicinal Plants (AREA)
Birds (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Biotechnology (AREA)
Inorganic Chemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Alternative & Traditional Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Reproductive Health (AREA)

NO20044768A 2002-05-29 2004-11-03 Sammensetning og terapeutisk anvendelse derav NO20044768L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0212405.5A GB0212405D0 (en)	2002-05-29	2002-05-29	Composition and its therapeutic use
PCT/GB2003/002295 WO2003101479A1 (fr)	2002-05-29	2003-05-27	Compositions a utilisations therapeutiques comprenant une vitamine, un sel metallique, de l'insuline ou une hormone de croissance

Publications (1)

Publication Number	Publication Date
NO20044768L true NO20044768L (no)	2005-02-24

Family

ID=9937661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044768A NO20044768L (no)	2002-05-29	2004-11-03	Sammensetning og terapeutisk anvendelse derav

Country Status (30)

Country	Link
EP (2)	EP1513546A1 (fr)
JP (3)	JP4362441B2 (fr)
CN (3)	CN1655811A (fr)
AP (1)	AP2004003177A0 (fr)
AR (1)	AR039895A1 (fr)
AT (1)	ATE468134T1 (fr)
AU (4)	AU2003236893A1 (fr)
BR (1)	BR0311371A (fr)
CA (1)	CA2487678A1 (fr)
DE (1)	DE60332578D1 (fr)
EA (1)	EA010548B1 (fr)
EC (1)	ECSP045458A (fr)
GB (3)	GB0212405D0 (fr)
IL (1)	IL164952A0 (fr)
IS (1)	IS7578A (fr)
MA (1)	MA27207A1 (fr)
ME (1)	MEP22908A (fr)
MX (1)	MXPA04011794A (fr)
MY (2)	MY139933A (fr)
NO (1)	NO20044768L (fr)
NZ (1)	NZ536360A (fr)
OA (1)	OA12862A (fr)
PL (1)	PL374199A1 (fr)
RS (1)	RS102304A (fr)
SM (1)	SM200300009B (fr)
TN (1)	TNSN04235A1 (fr)
TW (1)	TW200425892A (fr)
UY (1)	UY27827A1 (fr)
WO (1)	WO2003101479A1 (fr)
ZA (2)	ZA200210316B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0212405D0 (en) *	2002-05-29	2002-07-10	Insignion Holdings Ltd	Composition and its therapeutic use
GB0501654D0 (en) *	2005-01-26	2005-03-02	Veritron Ltd	Stabilised plant extract
GB0523257D0 (en) *	2005-11-15	2005-12-21	Veritron Ltd	Purification process
GB0710536D0 (en)	2007-06-01	2007-07-11	Veritron Ltd	Plant extract and its therapeutic use
DE102007030103A1 (de) *	2007-06-28	2009-01-02	Bode Chemie Gmbh & Co. Kg	Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel
GB0808974D0 (en) *	2008-05-16	2008-06-25	Veritron Ltd	Plant extract and its therapeutic use
EP2420228A1 (fr)	2010-08-05	2012-02-22	Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG	Composition comportant du rétinol, précurseur ou produit de réaction correspondant, et extrait végétal à partir d'au moins une plante de camomille pour le traitement du cancer
JP5756326B2 (ja) *	2011-04-14	2015-07-29	一丸ファルコス株式会社	キネシン抑制剤
CN104302670A (zh) *	2012-02-07	2015-01-21	Phi生物医药股份有限公司	制造用于经皮给药的透明质酸-蛋白结合体的方法以及由该方法制造的用于经皮给药的透明质酸-蛋白结合体
IL312865B2 (en) *	2013-09-11	2025-06-01	Eagle Biologics Inc	Liquid protein formulations containing viscosity-lowering agents
SG11201702614SA (en)	2014-10-01	2017-04-27	Eagle Biolog Inc	Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
FR3057773B1 (fr) *	2016-10-21	2020-06-19	Universite Claude Bernard Lyon 1	Nouvelles compositions antivirales pour le traitement des infections liees aux coronavirus
AU2021351504A1 (en) *	2020-09-30	2023-05-25	Reven Pharmaceuticals Inc.	Pharmaceutical compositions and methods for prevention and/or treatment of inflammation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK98342C (da) *	1959-06-16	1964-03-31	Henry Marinus Dr Christensen	Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
FR2126134A1 (en) *	1971-02-26	1972-10-06	Ates Ibrahim	Cyclophosphamide/magnesium compsns - with enhanced cytostatic activity
JPH02144075A (ja) *	1988-11-25	1990-06-01	Olympus Optical Co Ltd	薬剤放出装置
US5591709A (en) *	1991-08-30	1997-01-07	Life Medical Sciences, Inc.	Compositions and methods for treating wounds
HUT67319A (en) *	1991-08-30	1995-03-28	Life Medical Sciences Inc	Compositions for treating wounds
US6350784B1 (en) *	1996-02-12	2002-02-26	Meryl J. Squires	Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
JP2902886B2 (ja) *	1992-12-28	1999-06-07	三洋電機株式会社	記録ディスク演奏装置
CA2112539A1 (fr) *	1993-12-29	1995-06-30	Romualdo D. Candelario	Lotion medicamentee a base d'herbes medicinales
IT1269826B (it) *	1994-05-24	1997-04-15	Paolo Minoia	Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate
JPH08176002A (ja) *	1994-12-27	1996-07-09	Kao Corp	細胞接着抑制剤
US5639787A (en) *	1995-02-28	1997-06-17	The Center For The Improvement Of Human Functioning Int'l, Inc.	Therapeutic method for the treatment of cancer
ATE222598T1 (de) *	1996-04-19	2002-09-15	Nestle Sa	Menschliche immortalisierte colon- epithelialzellen
US6692961B1 (en) *	1996-10-11	2004-02-17	Invitrogen Corporation	Defined systems for epithelial cell culture and use thereof
JP2000086510A (ja) *	1998-09-16	2000-03-28	Oriza Yuka Kk	ヒスタミン遊離抑制剤
US6375975B1 (en) *	1998-12-21	2002-04-23	Generex Pharmaceuticals Incorporated	Pharmaceutical compositions for buccal and pulmonary application
AU6174900A (en) *	1999-07-08	2001-01-30	Patrick T. Prendergast	Use of flavones, coumarins and related compounds to treat infections
AU783283B2 (en) *	1999-08-30	2005-10-13	Ester C Company, The	Methods and compositions for selective cancer chemotherapy
JP2003514014A (ja) *	1999-11-15	2003-04-15	ティーガンガル，ハナマラディ	静脈注入のためのブドウ糖およびインスリン含有液体配合物
US6291533B1 (en) *	1999-12-22	2001-09-18	Vitamerica, Inc.	Dietary supplements for each specific blood type
HK1046848B (zh) *	2000-03-03	2006-04-13	李叔文	爱滋病特效药
ATE327747T1 (de) *	2000-10-09	2006-06-15	Matthias Dr Med Rath	Therapeutische kombination des ascorbats mit lysin und arginin für verhinderung und behandlung des krebses
GB0212405D0 (en) *	2002-05-29	2002-07-10	Insignion Holdings Ltd	Composition and its therapeutic use

2002
- 2002-05-29 GB GBGB0212405.5A patent/GB0212405D0/en not_active Ceased
- 2002-12-19 ZA ZA200210316A patent/ZA200210316B/xx unknown
- 2002-12-30 MY MYPI20024929A patent/MY139933A/en unknown
2003
- 2003-05-27 AT AT03253314T patent/ATE468134T1/de not_active IP Right Cessation
- 2003-05-27 AU AU2003236893A patent/AU2003236893A1/en not_active Abandoned
- 2003-05-27 RS YU102304A patent/RS102304A/sr unknown
- 2003-05-27 MX MXPA04011794A patent/MXPA04011794A/es active IP Right Grant
- 2003-05-27 EP EP03735812A patent/EP1513546A1/fr not_active Ceased
- 2003-05-27 DE DE60332578T patent/DE60332578D1/de not_active Expired - Lifetime
- 2003-05-27 ME MEP-229/08A patent/MEP22908A/xx unknown
- 2003-05-27 JP JP2004508834A patent/JP4362441B2/ja not_active Expired - Fee Related
- 2003-05-27 WO PCT/GB2003/002295 patent/WO2003101479A1/fr not_active Ceased
- 2003-05-27 CA CA002487678A patent/CA2487678A1/fr not_active Abandoned
- 2003-05-27 AP APAP/P/2004/003177A patent/AP2004003177A0/en unknown
- 2003-05-27 EA EA200401586A patent/EA010548B1/ru not_active IP Right Cessation
- 2003-05-27 OA OA1200400318A patent/OA12862A/en unknown
- 2003-05-27 EP EP03253314A patent/EP1366768B1/fr not_active Expired - Lifetime
- 2003-05-27 PL PL03374199A patent/PL374199A1/xx unknown
- 2003-05-27 GB GB0615918A patent/GB2427824A/en not_active Withdrawn
- 2003-05-27 BR BR0311371-0A patent/BR0311371A/pt not_active IP Right Cessation
- 2003-05-27 CN CNA03812405XA patent/CN1655811A/zh active Pending
- 2003-05-27 NZ NZ536360A patent/NZ536360A/en unknown
- 2003-05-27 GB GB0325839A patent/GB2392618B/en not_active Expired - Fee Related
- 2003-05-28 AR ARP030101877A patent/AR039895A1/es unknown
- 2003-05-28 AU AU2003204391A patent/AU2003204391B2/en not_active Ceased
- 2003-05-28 TW TW092114334A patent/TW200425892A/zh unknown
- 2003-05-28 UY UY27827A patent/UY27827A1/es not_active Application Discontinuation
- 2003-05-29 JP JP2003152738A patent/JP2004002429A/ja active Pending
- 2003-05-29 SM SM200300009A patent/SM200300009B/it unknown
- 2003-05-29 CN CNA2008101282264A patent/CN101380463A/zh active Pending
- 2003-05-29 MY MYPI20031995A patent/MY134288A/en unknown
- 2003-05-29 CN CNA031381995A patent/CN1466994A/zh active Pending
2004
- 2004-11-01 IL IL16495204A patent/IL164952A0/xx unknown
- 2004-11-03 NO NO20044768A patent/NO20044768L/no not_active Application Discontinuation
- 2004-11-25 ZA ZA200409551A patent/ZA200409551B/en unknown
- 2004-11-25 MA MA27966A patent/MA27207A1/fr unknown
- 2004-11-26 TN TNP2004000235A patent/TNSN04235A1/en unknown
- 2004-11-29 EC EC2004005458A patent/ECSP045458A/es unknown
- 2004-12-01 IS IS7578A patent/IS7578A/is unknown
2007
- 2007-07-06 AU AU2007203159A patent/AU2007203159B2/en not_active Ceased
2009
- 2009-02-12 JP JP2009029418A patent/JP2009143947A/ja active Pending
- 2009-03-06 AU AU2009200893A patent/AU2009200893A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AP2004003177A0 (en)	2004-12-31
AU2003204391B2 (en)	2005-08-04
CN101380463A (zh)	2009-03-11
EP1513546A1 (fr)	2005-03-16
IS7578A (is)	2004-12-01
TNSN04235A1 (en)	2007-03-12
MEP22908A (en)	2010-06-10
AU2009200893A1 (en)	2009-04-09
AU2007203159A1 (en)	2007-07-26
EP1366768B1 (fr)	2010-05-19
EP1366768A1 (fr)	2003-12-03
GB2392618B (en)	2007-02-21
MY134288A (en)	2007-11-30
BR0311371A (pt)	2005-04-05
ECSP045458A (es)	2005-05-30
JP4362441B2 (ja)	2009-11-11
CA2487678A1 (fr)	2003-12-11
JP2009143947A (ja)	2009-07-02
CN1466994A (zh)	2004-01-14
SM200300009A (it)	2004-12-01
MY139933A (en)	2009-11-30
GB2427824A (en)	2007-01-10
RS102304A (sr)	2006-12-15
EA200401586A1 (ru)	2005-04-28
AU2003204391A1 (en)	2003-12-18
JP2004002429A (ja)	2004-01-08
OA12862A (en)	2006-09-15
IL164952A0 (en)	2005-12-18
MXPA04011794A (es)	2005-07-05
GB0325839D0 (en)	2003-12-10
ZA200210316B (en)	2003-07-04
WO2003101479A1 (fr)	2003-12-11
ZA200409551B (en)	2005-10-11
NZ536360A (en)	2008-03-28
GB0212405D0 (en)	2002-07-10
DE60332578D1 (de)	2010-07-01
SM200300009B (it)	2004-12-01
TW200425892A (en)	2004-12-01
GB2392618A (en)	2004-03-10
GB0615918D0 (en)	2006-09-20
AU2007203159B2 (en)	2009-03-26
AR039895A1 (es)	2005-03-09
EA010548B1 (ru)	2008-10-30
UY27827A1 (es)	2003-12-31
PL374199A1 (en)	2005-10-03
CN1655811A (zh)	2005-08-17
ATE468134T1 (de)	2010-06-15
MA27207A1 (fr)	2005-01-03
AU2003236893A1 (en)	2003-12-19
JP2006500324A (ja)	2006-01-05

Legal Events

Date	Code	Title	Description
2010-07-05	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20053077L (no)	2005-09-22	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20051575L (no)	2005-04-25	Bruk av quinazolinderivatet ZD6474 i kombinasjon med gemcitabin og valgfritt ioniserende straling i behandling av sykdommer forbundet med angiogenese og/eller okt kar-gjennomtrengelighet
ATE372324T1 (de)	2007-09-15	Substituierte heteroarylverbindungen als inhibitoren von proteintyrosinphosphatasen
NO20063200L (no)	2006-09-12	Preparat for forbedring av hud-, har og pelshelse inneholdende flavanoner
NO20063373L (no)	2006-09-21	CD40-antistoff-formuleringer og fremgangsmater
SG169224A1 (en)	2011-03-30	Method for treatment of tumors using nordihydrogualaretic acid derivatives
ATE442142T1 (de)	2009-09-15	Fredericamycin-derivate als arzneimittel zur tumorbehandlung
CY1116215T1 (el)	2017-02-08	Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BRPI0512397A (pt)	2008-03-04	composto,produto farmacêutico, métodos para suprimir a metástase de cáncer ou o crescimento do cáncer, para prevenir ou tratar uma doença ou condição, para controlar a função placentária, para melhorar a função gonadal, para induzir ou estimular a ovulação, para promover a secreção do hormÈnio gonadotrópico ou promover a secreção do hormÈnio sexual, para suprimir a secreção do hormÈnio gonadotrópico ou suprimir a secreção do hormÈnio sexual, para infra regular hormÈnio gonadrotópico ou hormÈnio sexual, e a proteìna ot7t175 humana, e para realçar a estabilidade no sangue, uso do composto, e, agente para suprimir a secreção do hormÈnio gonadotrópico ou um agente para suprimir a secreção do hormÈnio sexual
BR0208150A (pt)	2004-03-02	Antagonistas de mch e sua aplicação no tratamento da obesidade
AP2004003177A0 (en)	2004-12-31	Composition and its therapeutic use
DK1098643T3 (da)	2004-05-24	Phenylacetylglutamin, phenylacetylisoglutamin og/eller phenylacetat til behandling af neoplastiske sygdomme
DE60233261D1 (de)	2009-09-17	Inhibitoren von humanem adam-10
BR0316057A (pt)	2005-09-20	Métodos de tratar, controlar ou prevenir um câncer especìfico e uma doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com a terapia de radiação, terapia hormonal, terapia biológica ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit
DE502004008819D1 (de)	2009-02-26	Medikament zur wachstumsinhibierung von tumoren
DE602004016950D1 (de)	2008-11-20	Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
DK1635776T5 (da)	2009-04-27	Lipidoverf ringsproteinsystemer samt deres kosmetiske dermatologiske anvendelse
DE60119976D1 (en)	2006-06-29	Thixotropes nasenspray
JP2004002429A5 (fr)	2009-04-30
WO2002045737A3 (fr)	2004-01-08	Procedes de traitement mettant en application mda-7 humain
YU31104A (sh)	2006-08-17	Inhibicija virusa n-dokozanolom
MX2024009890A (es)	2024-12-06	Factores terapeuticos para el tratamiento de enfermedades poliglutaminicas
EA200700983A1 (ru)	2008-04-28	Применение андрогенов для снижения вероятности приобретения или лечения старения кожи
NO20051159L (no)	2005-04-26	Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
NO20056005L (no)	2006-02-24	Terapautiske midler